| Synaptic proximity enables NMDAR signalling to promote brain metastasis Q Zeng, IP Michael, P Zhang, S Saghafinia, G Knott, W Jiao, BD McCabe, ... Nature 573 (7775), 526-531, 2019 | 396 | 2019 |
| CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer Q Zeng, W Li, D Lu, Z Wu, H Duan, Y Luo, J Feng, D Yang, L Fu, X Yan Proceedings of the National Academy of Sciences 109 (4), 1127-1132, 2012 | 248 | 2012 |
| CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis T Jiang, J Zhuang, H Duan, Y Luo, Q Zeng, K Fan, H Yan, D Lu, Z Ye, ... Blood, The Journal of the American Society of Hematology 120 (11), 2330-2339, 2012 | 219 | 2012 |
| Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization C Zheng, Y Qiu, Q Zeng, Y Zhang, D Lu, D Yang, J Feng, X Yan The international journal of biochemistry & cell biology 41 (11), 2163-2172, 2009 | 95 | 2009 |
| GKAP acts as a genetic modulator of NMDAR signaling to govern invasive tumor growth L Li, Q Zeng, A Bhutkar, JA Galván, E Karamitopoulou, D Noordermeer, ... Cancer Cell 33 (4), 736-751. e5, 2018 | 64 | 2018 |
| Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS H Duan, S Xing, Y Luo, L Feng, I Gramaglia, Y Zhang, D Lu, Q Zeng, ... Scientific reports 3 (1), 1687, 2013 | 61 | 2013 |
| Impaired tumor angiogenesis and VEGF-induced pathway in endothelial CD146 knockout mice Q Zeng, Z Wu, H Duan, X Jiang, T Tu, D Lu, Y Luo, P Wang, L Song, ... Protein & cell 5 (6), 445-456, 2014 | 58 | 2014 |
| Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion Q Zeng, S Saghafinia, A Chryplewicz, N Fournier, L Christe, YQ Xie, ... Science 378 (6621), 2022 | 32 | 2022 |
| Quantitative proteomics reveals ER-α involvement in CD146-induced epithelial-mesenchymal transition in breast cancer cells Q Zeng, P Zhang, Z Wu, P Xue, D Lu, Z Ye, X Zhang, Z Huang, J Feng, ... Journal of Proteomics 103, 153-169, 2014 | 31 | 2014 |
| CMSO EA Allen, A Baflast, SB Nejad, E Brindle, N Rae, L Cai, K Cheng, ... | 2 | 2002 |
| Fmrp and cancer treatment Q Zeng, D Hanahan US Patent App. 17/967,888, 2023 | | 2023 |
| FMRP and cancer treatment Q Zeng, D Hanahan US Patent 11,473,087, 2022 | | 2022 |
| FMRP and cancer treatment Q Zeng, D Hanahan | | 2020 |
Peng ZhangUniversity of Maryland School of Medicine在 ihv.umaryland.edu 的电子邮件经过验证
